scroll
LEARN MORE
Thursday 30th Nov – ASX200 -1pt, Iress (IRE) & Origin (ORG)
Close
November update, performance review & 4 stocks we like here and now!
Close
Thursday 30th November – Dow Jones +13pts, SPI +5pts
Close
14 DAYS FREE ACCESS
Join Market Matters and get full access
to all our Opinion + Action
ASX.NAN $4.33
20 MINUTE DELAYED
ANALYSIS
OPINION
ACTION
i
PERFORMANCE
i
| SHARE PRICE ACTIVITY | |
|---|---|
| Last (Price) | 4.33 |
| Change | 0.00 (0.00) |
| Bid / Ask | 4.31 - 4.35 |
| Volume | 0 |
| Volume (3mths avg) | 0 |
| Turnover | 0 |
| Open | 0.00 |
| Day Range | 4.31 - 4.41 |
| VWAP | 0.00 |
| Prev Close | 4.33 |
| Last Trade | 01/12 6:10am (AEST) |
i
| KEY INFORMATION | |
|---|---|
| Sector | Healthcare |
| Shares Issued | 246,874,565 |
| NTA/Share | 0.00 |
| Last Dividend | 0.00 |
| Dividend Ex Date | 0 |
| Dividend Pay Date | 12 MAR 2008 |
i
| CURRENT () | |
|---|---|
| Revenue | |
| EBITDA | |
| Profit | |
| Earnings Per Share (EPS) | 0 |
| Dividend Per Share (DPS) | 0 |
| Yield % | 0.00 |
| Market Cap | 0 |
| Price to Earnings Ratio (P/E) | 65.61 |
i
TARGET PRICE FORECAST
i
| ESTIMATES () | |
|---|---|
| Revenue | 0.00 |
| EBITDA | 0.00 |
| Profit | 0.00 |
| Earnings Per Share (EPS) | 0.00 |
| Dividend Per Share (DPS) | 0.00 |
i
BROKER CONSENSUS RECOMMENDATION
BUY
SELL
Target Price
0.00
Lt Growth Rate
0.00
Recommendation ()
0.00
ACTION
NAN
UPDATED
24/02/2021 17:00
We are becoming more positive NAN into recent lows ~$5
Add To Hit List
Business Summary
Nanosonics (NAN) develops, and commercializes a range of disinfection and sterilization technologies that are utilized for infection control and decontamination.
Relevant suggested news and content from the site
Podcast
LISTEN
Thursday 30th Nov – ASX200 -1pt, Iress (IRE) & Origin (ORG)
Daily Podcast Direct from the Desk
Video
WATCH
November update, performance review & 4 stocks we like here and now!
Recorded Wednesday 14th November 2023
Podcast
LISTEN
Thursday 30th November – Dow Jones +13pts, SPI +5pts
Daily Podcast Direct from the Desk
Only available to Members
Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required
For membership options and pricing.
Click here
